XUHC:LSE:LSE-Xtrackers MSCI USA Health Care UCITS ETF 1D (USD)

ETF | Others |

Last Closing

USD 58.64

Change

+0.98 (+1.70)%

Market Cap

USD 0.80B

Volume

1.27K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-1.04 (-0.37%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+4.50 (+2.37%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.28 (-0.91%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.42%)

USD 559.82B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.44%)

USD 500.71B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+1.06%)

USD 266.08B
0QZO:LSE 0QZO

+0.15 (+0.16%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.11 (+0.35%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

-4.06 (-2.34%)

USD 202.26B

ETFs Containing XUHC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.18% 50% F 53% F
Dividend Return 0.63% 56% F 73% C
Total Return 6.81% 52% F 55% F
Trailing 12 Months  
Capital Gain 12.26% 52% F 58% F
Dividend Return 1.32% 49% F 75% C
Total Return 13.58% 54% F 60% D-
Trailing 5 Years  
Capital Gain 66.52% 77% C+ 80% B-
Dividend Return 3.80% 45% F 49% F
Total Return 70.32% 79% B- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 10.17% 72% C 73% C
Dividend Return 10.62% 73% C 74% C
Total Return 0.45% 48% F 52% F
Risk Return Profile  
Volatility (Standard Deviation) 10.85% 64% D 78% C+
Risk Adjusted Return 97.84% 97% N/A 98% N/A
Market Capitalization 0.80B 77% C+ 66% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.